FDA Approved: EMTRICITABINE, RILPIVIRINE, TENOFOVIR DISOPROXIL FUMARATE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves a generic fixed-dose combination tablet containing emtricitabine, rilpivirine, and tenofovir disoproxil fumarate for treatment of HIV-1 infection. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• emtricitabine, rilpivirine, tenofovir disoproxil fumarate (emtricitabine; rilpivirine; tenofovir disoproxil fumarate)

Snippet

ORIG AP for EMTRICITABINE, RILPIVIRINE, TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE, RILPIVIRINE, TENOFOVIR DISOPROXIL FUMARATE)